PMID: 7014489Jan 1, 1981Paper

Therapeutic usefulness of amitriptyline in spastic colon syndrome

International Journal of Psychiatry in Medicine
M J SteinhartM L Zarr

Abstract

The therapeutic efficacy of amitriptyline in irritable bowel was studied in a cross-over double-blind trial, employing fourteen patients whose symptoms were rated as Class II or worse on an arbitrarily-defined interval scale and who had not benefited from previous trials of anticholinergics, anticholinergic-sedative combinations, and bulk-forming agents. During the study, patients rated their own symptoms and the interviewer rated their symptoms using the same scale. Average scores for the patients while on drug showed significant improvement compared to pre-test level. No placebo or drug carry-over effects could be demonstrated. Inasmuch as amitriptyline is effective in this context at dosages subtherapeutic with regard to depression, the authors suggest that a central (perhaps anticholinergic) mechanism of action is responsible.

References

Feb 1, 1977·Archives of General Psychiatry·S H Snyder, H I Yamamura
Oct 1, 1977·Archives of General Psychiatry·H A GrossR R Fieve
Nov 16, 1978·The New England Journal of Medicine·L E Hollister
Feb 4, 1978·Lancet·E M Frew
Nov 21, 1977·JAMA : the Journal of the American Medical Association·J L DavisJ D Wallin
Jan 1, 1978·The Journal of International Medical Research·K Lüttecke
Dec 1, 1977·The British Journal of Venereal Diseases·J SchneiderM C Kew
Nov 23, 1978·The New England Journal of Medicine·L E Hollister
Dec 1, 1978·Journal of Human Stress·T P Almy
Jan 1, 1975·Psychosomatics·J Ananth
Nov 16, 1973·Nature·M J Brimble, D I Wallis
Oct 1, 1973·Australian and New Zealand Journal of Medicine·P Baume, J Cuthbert
Oct 5, 1974·British Medical Journal·G Dotevall, E Groll
Jan 4, 1973·The New England Journal of Medicine·M D Esler, K J Goulston
May 15, 1974·Biochemical Pharmacology·F S Messiha, J P Morgan
Feb 1, 1972·Journal of Psychosomatic Research·A E Philip, E L Cay
Jan 20, 1968·The Medical Journal of Australia·J E Gault
Mar 21, 1980·JAMA : the Journal of the American Medical Association·E W Massey, T L Riley
Mar 1, 1959·The American Journal of Digestive Diseases·A M KASICHJ W MILLER
Oct 1, 1973·Molecular Biology Reports·J Brouwer, R J Planta

❮ Previous
Next ❯

Citations

Mar 1, 1987·Digestive Diseases and Sciences·D S GreenbaumN A Halvorsen
Nov 1, 1994·Digestive Diseases and Sciences·R E Clouse
Jul 1, 1993·Journal of Affective Disorders·M Swiatkowski, J K Rybakowski
May 3, 2005·Gastroenterology Clinics of North America·Philip Schoenfeld
Nov 4, 2000·The American Journal of Medicine·J L JacksonK Kroenke
Mar 15, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Marshall PitzCharles N Bernstein
Aug 20, 2002·Journal of Clinical Gastroenterology·Arnold Wald
Jan 2, 2007·Southern Medical Journal·Mihaela Podovei, Braden Kuo
Dec 20, 2008·Drugs·Bénédicte VerduAlexandre Berney
May 8, 2008·World Journal of Gastroenterology : WJG·Christopher W Hammerle, Christina M Surawicz
Aug 5, 2009·World Journal of Gastroenterology : WJG·Heitham Abdul-BakiAla I Sharara
Mar 1, 1983·Psychosomatics·P R Latimer
Feb 6, 2008·Alimentary Pharmacology & Therapeutics·H VahediR Malekzadeh
Sep 1, 1986·General Hospital Psychiatry·S A Cohen-ColeJ L Houpt
May 27, 1992·The American Journal of Medicine·R E Clouse
May 12, 2016·Inflammatory Bowel Diseases·Gregory ThorkelsonEva Szigethy
Jul 18, 2006·Alimentary Pharmacology & Therapeutics·J TackG Fisher
Sep 5, 2006·Alimentary Pharmacology & Therapeutics·E A MayerS Bradesi
Jul 1, 1989·Medicinal Research Reviews·W J KinnierC Kaiser
Oct 29, 2000·The American Journal of Gastroenterology·W C OrrM J Harnish
Aug 26, 1998·Journal of Gastroenterology and Hepatology·M RajagopalanJ John
Apr 14, 2017·The Cochrane Database of Systematic Reviews·Katharine DudleySaskia De Haan
Feb 20, 2004·The Cochrane Database of Systematic Reviews·L O MarquesB G O Soares
Jan 27, 2018·The Journal of Nervous and Mental Disease·H J Rogier HoendersJoop T V M de Jong
Dec 21, 2004·Alimentary Pharmacology & Therapeutics·D Lesbros-PantoflickovaA L Blum
May 1, 1988·Postgraduate Medicine·J R Marshall
Aug 1, 1994·Alimentary Pharmacology & Therapeutics·R E ClouseD H Alpers
Apr 1, 1994·Alimentary Pharmacology & Therapeutics·D A GorardM J Farthing
Sep 2, 1998·The American Journal of Physiology·A B GorelickW L Hasler
Jul 17, 1989·The Medical Journal of Australia·J E Kellow, P M Langeluddecke
Nov 11, 2021·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·Andrew LambarthAlan Fayaz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
C LunardiM L Pacor
Journal of Affective Disorders
W W FleischhackerB Unterweger
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
S KasperR Wolf
© 2021 Meta ULC. All rights reserved